Design Therapeutics (DSGN) Non-cash Items (2020 - 2025)

Design Therapeutics has disclosed Non-cash Items across 6 years of filings, most recently posting $6.7 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $6.7 million, down 99.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.7 million (down 99.97% YoY), and the FY2025 annual result was $6.7 million, down 99.97% from the prior year.
• Non-cash Items came in at $6.7 million for Q4 2025 at Design Therapeutics, down from $19.6 billion in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $19.6 billion in Q4 2024 to a low of $6.7 million in Q4 2025.
• The 5-year median for Non-cash Items is $1.1 billion (2023), against an average of $6.3 billion.
• Across the five-year window, Non-cash Items jumped 29703.5% in 2022 and slumped 99.97% in 2025, its largest moves.
• Design Therapeutics' Non-cash Items stood at $35.3 million in 2021, then surged by 29703.5% to $10.5 billion in 2022, then plunged by 89.41% to $1.1 billion in 2023, then soared by 1661.37% to $19.6 billion in 2024, then plunged by 99.97% to $6.7 million in 2025.
• The last three Non-cash Items figures came in at $6.7 million (Q4 2025), $19.6 billion (Q4 2024), and $1.1 billion (Q4 2023), per Business Quant data.